A detailed history of Polen Capital (Polen Capital Management LLC) transactions in Zoetis Inc. stock. As of the latest transaction made, Polen Capital Management LLC holds 6,366,653 shares of ZTS stock, worth $1.12 Billion. This represents 3.21% of its overall portfolio holdings.

Number of Shares
6,366,653
Previous 7,046,051 9.64%
Holding current value
$1.12 Billion
Previous $1.22 Billion 1.83%
% of portfolio
3.21%
Previous 3.06%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$172.58 - $196.48 $117 Million - $133 Million
-679,398 Reduced 9.64%
6,366,653 $1.24 Billion
Q2 2024

Aug 12, 2024

BUY
$145.54 - $178.83 $5.96 Million - $7.32 Million
40,937 Added 0.58%
7,046,051 $1.22 Billion
Q1 2024

May 10, 2024

BUY
$165.67 - $199.94 $337 Million - $407 Million
2,033,370 Added 40.9%
7,005,114 $1.19 Billion
Q4 2023

Feb 13, 2024

SELL
$151.44 - $200.09 $29.1 Million - $38.4 Million
-192,137 Reduced 3.72%
4,971,744 $981 Million
Q3 2023

Nov 13, 2023

SELL
$167.14 - $192.77 $39.1 Million - $45.1 Million
-234,037 Reduced 4.34%
5,163,881 $898 Million
Q2 2023

Aug 11, 2023

SELL
$160.94 - $186.23 $21.8 Million - $25.3 Million
-135,756 Reduced 2.45%
5,397,918 $930 Million
Q1 2023

May 11, 2023

SELL
$145.48 - $175.02 $9.94 Million - $12 Million
-68,355 Reduced 1.22%
5,533,674 $921 Million
Q4 2022

Feb 13, 2023

SELL
$131.14 - $157.47 $47.4 Million - $57 Million
-361,819 Reduced 6.07%
5,602,029 $821 Million
Q3 2022

Nov 04, 2022

SELL
$148.29 - $182.55 $4.01 Million - $4.94 Million
-27,043 Reduced 0.45%
5,963,848 $884 Million
Q2 2022

Aug 10, 2022

SELL
$155.97 - $200.09 $112 Million - $143 Million
-715,481 Reduced 10.67%
5,990,891 $1.03 Billion
Q1 2022

May 12, 2022

SELL
$181.39 - $234.03 $565 Million - $729 Million
-3,113,415 Reduced 31.71%
6,706,372 $1.26 Billion
Q4 2021

Feb 11, 2022

BUY
$193.69 - $247.03 $45.9 Million - $58.6 Million
237,161 Added 2.47%
9,819,787 $2.4 Billion
Q3 2021

Nov 10, 2021

SELL
$189.29 - $209.69 $440 Million - $488 Million
-2,325,133 Reduced 19.53%
9,582,626 $1.86 Billion
Q2 2021

Aug 12, 2021

BUY
$155.9 - $187.99 $49.9 Million - $60.2 Million
320,158 Added 2.76%
11,907,759 $2.22 Billion
Q1 2021

May 12, 2021

BUY
$144.0 - $169.39 $35.2 Million - $41.4 Million
244,701 Added 2.16%
11,587,601 $1.82 Billion
Q4 2020

Feb 11, 2021

BUY
$157.07 - $174.35 $50 Million - $55.5 Million
318,254 Added 2.89%
11,342,900 $1.88 Billion
Q3 2020

Nov 12, 2020

BUY
$137.1 - $165.37 $33.5 Million - $40.4 Million
244,464 Added 2.27%
11,024,646 $1.82 Billion
Q2 2020

Aug 13, 2020

BUY
$111.92 - $142.53 $113 Million - $144 Million
1,013,095 Added 10.37%
10,780,182 $1.48 Billion
Q1 2020

May 11, 2020

SELL
$92.66 - $144.94 $98.1 Million - $154 Million
-1,059,072 Reduced 9.78%
9,767,087 $1.15 Billion
Q4 2019

Feb 06, 2020

BUY
$116.25 - $133.25 $34.1 Million - $39.1 Million
293,598 Added 2.79%
10,826,159 $1.43 Billion
Q3 2019

Nov 12, 2019

BUY
$112.57 - $128.43 $38.7 Million - $44.2 Million
344,007 Added 3.38%
10,532,561 $1.31 Billion
Q2 2019

Aug 12, 2019

BUY
$97.98 - $114.28 $8.46 Million - $9.87 Million
86,364 Added 0.85%
10,188,554 $1.16 Billion
Q1 2019

May 13, 2019

BUY
$81.56 - $100.67 $44.7 Million - $55.2 Million
548,623 Added 5.74%
10,102,190 $1.02 Billion
Q4 2018

Feb 12, 2019

BUY
$79.28 - $95.27 $14.2 Million - $17 Million
178,893 Added 1.91%
9,553,567 $817 Million
Q3 2018

Nov 13, 2018

BUY
$83.5 - $93.23 $6.65 Million - $7.42 Million
79,594 Added 0.86%
9,374,674 $858 Million
Q2 2018

Aug 09, 2018

BUY
$79.9 - $89.2 $28.1 Million - $31.3 Million
351,447 Added 3.93%
9,295,080 $792 Million
Q1 2018

May 11, 2018

BUY
$71.51 - $84.69 $356 Million - $421 Million
4,974,081 Added 125.31%
8,943,633 $747 Million
Q4 2017

Feb 09, 2018

BUY
$63.24 - $72.8 $251 Million - $289 Million
3,969,552
3,969,552 $286 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.2B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track Polen Capital's Portfolio

Track Polen Capital Portfolio

Follow Polen Capital (Polen Capital Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Polen Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Polen Capital Management LLC and Polen Capital with notifications on news.